1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. IMMUNITYBIO INC
ImmunityBio Inc
XNAS: IBRX
7.22 -0.14 (-1.90%)
9.8M
XNAS Volume

XNAS 22 Jun, 2026 4:17 PM (EDT)

Watchlist

Portfolio

Alert

ImmunityBio Inc - IBRX - stock price prediction, stock price target, analyst ratings from 3 analysts

ImmunityBio Inc has a share price target of US$ 13, revenue growth forecast of 96.3%, and profit growth estimate of -150.6% for FY26, based on top 3 analyst calls.